8 July 2025 Clinical Public Health Hep C trial backs sofosbuvir–daclatasvir as potent first-line option
15 April 2025 Hepatocellular carcinoma Research Three treatments are better than one for liver cancer
18 March 2025 Hepatology Immunology Pharmaceuticals Use antivirals in patients at risk of hep B reactivation
24 September 2024 Gastroenterology Pharmaceuticals Research Lower dose infliximab just as effective as higher doses in ASUC
27 August 2024 Addiction Alcohol Pharmaceuticals Medications for alcohol use disorder: the time is now
